Sign in to view content

Senolytic Candidate UBX1325 for Diabetic Macular Edema: The BEHOLD Phase 2 and ASPIRE Phase 2b Trials

Dante Joseph Pieramici, MD

Video
Published 2025

Related

Multicenter, Head-to-Head, Real-World Validation Study of Artificial Intelligence Diabetic Retinopathy Screening Systems (AIDRSS)
Aaron Y Lee, MD, MSCI
Annual Meeting Talks
2020
Neighborhood-Level Characteristics Associated With Delay in Surgery and Loss to Follow-up in Tractional Retinal Detachment Due to Proliferative Diabetic Retinopathy
Sally S Ong, MD
Annual Meeting Talks
2025
Aflibercept Monotherapy vs Initial Bevacizumab Followed by Aflibercept if Needed for Treatment of Center-Involved Diabetic Macular Edema
Chirag D. Jhaveri, MD, FASRS
Updates from the Field
2022

Category: Retinal Vascular Disease

See more